CH402846A - Verfahren zur Herstellung von 19-Nor-4,9(10)-Steroiden - Google Patents

Verfahren zur Herstellung von 19-Nor-4,9(10)-Steroiden

Info

Publication number
CH402846A
CH402846A CH70261A CH70261A CH402846A CH 402846 A CH402846 A CH 402846A CH 70261 A CH70261 A CH 70261A CH 70261 A CH70261 A CH 70261A CH 402846 A CH402846 A CH 402846A
Authority
CH
Switzerland
Prior art keywords
steroids
preparation
Prior art date
Application number
CH70261A
Other languages
English (en)
Inventor
Perelman Melvin
Farkas Eugene
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH402846A publication Critical patent/CH402846A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
CH70261A 1960-01-22 1961-01-21 Verfahren zur Herstellung von 19-Nor-4,9(10)-Steroiden CH402846A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4001A US3086027A (en) 1960-01-22 1960-01-22 19-nor-4, 9(10)-steroids and process

Publications (1)

Publication Number Publication Date
CH402846A true CH402846A (de) 1965-11-30

Family

ID=21708638

Family Applications (1)

Application Number Title Priority Date Filing Date
CH70261A CH402846A (de) 1960-01-22 1961-01-21 Verfahren zur Herstellung von 19-Nor-4,9(10)-Steroiden

Country Status (6)

Country Link
US (1) US3086027A (de)
BE (1) BE599411A (de)
CH (1) CH402846A (de)
FR (1) FR993M (de)
GB (1) GB956251A (de)
OA (1) OA03370A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250793A (en) * 1963-06-19 1966-05-10 Merck & Co Inc 17alpha-halogenated hydrocarbon derivatives of estra-4, 9-diene 3beta, 17-diols
US3211764A (en) * 1963-09-25 1965-10-12 American Cyanamid Co 19-norandrostadienes and method of preparing the same
US3424745A (en) * 1964-05-27 1969-01-28 Roussel Uclaf Novel process for the preparation of trienic steroid derivatives
BE665514A (de) * 1964-06-16
NL127071C (de) * 1964-12-31
NL6517141A (de) * 1964-12-31 1966-07-04
US3370071A (en) * 1965-06-01 1968-02-20 Merck & Co Inc 3-keto-13beta-alkyl-17beta-acetyl-gona-4, 9-dienes and process
US3424768A (en) * 1965-08-17 1969-01-28 Searle & Co 17alpha-alkynylestra-4,9(10)-diene-3beta,17beta-diols and esters thereof
US3423404A (en) * 1965-10-21 1969-01-21 Searle & Co (optionally 17-alkylated) estra-4,9(10)-diene - 3alpha/3beta,17beta - diols and esters corresponding
GB1108276A (en) * 1966-03-14 1968-04-03 British Drug Houses Ltd 17ª‡-alka-1',3'-diynyl-oestra-4,9(10)-dien-3-ones
US3424769A (en) * 1966-04-04 1969-01-28 Syntex Corp Process for the preparation of novel 6alpha-methyl-delta4,9(10)- diene steroids
US3461118A (en) * 1966-10-17 1969-08-12 Syntex Corp 3beta-tetrahydrofuranyloxy - and 3beta-tetrahydropyranyloxyestra - 4,9(10) - dienes and -4,9(10),11-trienes,their preparation and intermediates thereof
US3875188A (en) * 1968-04-10 1975-04-01 Eugene E Galantay 17-Beta-alpha-lower alkyl allene-substituted steroids
US3761591A (en) * 1970-02-20 1973-09-25 Roussel Uclaf Novel pregnadiene
FR2407940A1 (fr) * 1977-11-08 1979-06-01 Roussel Uclaf Nouveaux derives steroides 17 a-aryle, ou 17 a-heteroaryle, leur procede de preparation et leur application comme medicament
US4157349A (en) * 1978-03-13 1979-06-05 Sterling Drug Inc. Dehydrohalogenation process
DE3027908A1 (de) * 1980-07-21 1982-03-18 Schering Ag, 1000 Berlin Und 4619 Bergkamen 16 (beta) -ethylsteroide, diese enthaltende praeparate und verfahren zu ihrer herstellung
FR2495621A1 (fr) * 1980-12-05 1982-06-11 Roussel Uclaf Nouveaux derives de l'estra 4,9-diene, leur procede de preparation et leur application comme medicaments
AU3162200A (en) * 1999-03-08 2000-09-28 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
PL202999B1 (pl) * 1999-12-02 2009-08-31 Organon Nv Androgeny zawierające pierścień cyklopropanowy w pozycjach 14, 15 i zastosowanie takich androgenów
BR0016092A (pt) 1999-12-02 2002-07-30 Akzo Nobel Nv Composto, uso de um composto kit para contracepção hormonal em um macho, e, método de tratamento

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729654A (en) * 1954-05-19 1956-01-03 Searle & Co 10-hydroxy-3-ketosteroids

Also Published As

Publication number Publication date
OA03370A (fr) 1970-12-15
US3086027A (en) 1963-04-16
GB956251A (en) 1964-04-22
BE599411A (fr) 1961-07-24
FR993M (de) 1961-12-11

Similar Documents

Publication Publication Date Title
CH402846A (de) Verfahren zur Herstellung von 19-Nor-4,9(10)-Steroiden
AT288340B (de) Verfahren zur Herstellung von Aminonitroalkanen
CH393338A (de) Verfahren zur Herstellung von 1-Aryl-4,5-dihalogenpyridazonen-(6)
CH395094A (de) Verfahren zur Herstellung von 6-Chlor-benzisothiazolon
CH398622A (de) Verfahren zur Herstellung von 2,4-Bis-amino-6-trichlormethyl-s-triazinen
CH405326A (de) Verfahren zur Herstellung von 1,3-Diaryl-pyrazolinen
AT245580B (de) Verfahren zur Herstellung von 1,6-Dibrom-1,6-didesozy-D-mannit
CH402859A (de) Verfahren zur Herstellung von a-Pyrrolidino-valerophenonen
CH424758A (de) Verfahren zur Herstellung von 2,6-Dichlorbenzaldoxim
CH407989A (de) Verfahren zur Herstellung von 2,2-Dihalogencyclopropancarbonsäuren
CH412875A (de) Verfahren zur Herstellung von 6a-Methyl-16-methylen-steroiden
CH400167A (de) Verfahren zur Herstellung von Arylaminopyrazolen
CH388969A (de) Verfahren zur Herstellung von 4,4'-Methenyl-bis-(pyrazolonen-(5))
AT242867B (de) Verfahren zur Herstellung von Dihydroouabain
CH406231A (de) Verfahren zur Herstellung von 3-Hydroxymethyl-1-(5-nitrofurfuryliden-amino)-hydantoïn
CH399449A (de) Verfahren zur Herstellung von 4-Hydroxy-3-keto- 4-steroiden
CH383974A (de) Verfahren zur Herstellung von 2-Amino-oxazolen
CH428763A (de) Verfahren zur Herstellung von Enhalogeniden von Grisantrion-(3,2',4')
CH412905A (de) Verfahren zur Herstellung von cycloalkylierten 2,3-Dihydro-1,4-benzthiazinen
CH405329A (de) Verfahren zur Herstellung von Sulfanilamidothiadiazolen
CH385239A (de) Verfahren zur Herstellung von 5-Nitrofurfuralazinen
AT226660B (de) Verfahren zur Herstellung von 2,3-Dibrom- oder 2-Brom-3-chlor-propen-1
AT217468B (de) Verfahren zur Herstellung von 2-Thion-4,4,6-trimethyl-tetrahydropyrimidin
CH417556A (de) Verfahren zur Herstellung von 1,3-Dialkylcyclobutenolonen
CH409945A (de) Verfahren zur Herstellung von 1,2-Dehydro-17a-methyltestosteronen